Financials in USD. Standardized financial statements.
A compact view of how Insight Molecular Diagnostics Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $4.05M | $1.88M | $1.50M | $958,000 | $2.20M | $1.22M | $0 | $0 | $0 | $0 |
| Revenue Growth? | +115.6% | +25.1% | +56.9% | -56.4% | +80.8% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.87M | $1.14M | $1.09M | $976,000 | $778,000 | $1.85M | $344,000 | $559,000 | $580,000 | $387,000 |
| Gross Profit? | $190,000 | $740,000 | $413,000 | -$18,000 | $1.42M | -$639,000 | -$344,000 | -$559,000 | -$580,000 | -$387,000 |
| Gross Margin? | +4.7% | +39.3% | +27.5% | -1.9% | +64.6% | -52.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $30.77M | $61.78M | $25.55M | $17.98M | $55.15M | $29.07M | $22.24M | $15.20M | $18.85M | $11.14M |
| Operating Income? | -$30.58M | -$61.04M | -$25.14M | -$18.00M | -$53.73M | -$29.71M | -$22.24M | -$15.20M | -$18.85M | -$11.14M |
| EBITDA? | -$28.38M | -$59.02M | -$23.12M | -$13.31M | -$48.46M | -$30.54M | -$21.89M | -$15.20M | -$18.27M | -$11.14M |
| Income Before Tax | -$50.22M | -$60.66M | -$24.86M | -$18.61M | -$52.87M | -$31.19M | -$22.43M | -$15.75M | -$19.38M | -$11.17M |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$9.26M | -$1.25M | $0 | $0 | $0 | $0 |
| Net Income? | -$50.22M | -$60.66M | -$27.78M | -$72.90M | -$64.10M | -$29.93M | -$22.33M | -$15.75M | -$19.38M | -$11.17M |
| EPS? | $-1.65 | $-4.66 | $-3.75 | $-20.00 | $-14.40 | $-9.14 | $-8.71 | $-8.32 | $-12.83 | $-8.42 |
| Diluted EPS? | $-1.65 | $-4.66 | $-3.75 | $-20.00 | $-14.40 | $-9.14 | $-8.71 | $-8.32 | $-12.83 | $-8.42 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality